Donor-transmitted toxoplasmosis in liver transplant recipients: A case report and literature review

Transplant Infectious Disease

Volumn 9, Issue 2, 2007, Pages 132-136

  Assi, M A ^a   Rosenblatt, J E ^a   Marshall, W F ^a,b  

^a Mayo Clinic College of Medicine   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Liver transplant; Toxoplasmosis

Indexed keywords

ATOVAQUONE; CEFEPIME; CLINDAMYCIN; FOLINIC ACID; PYRIMETHAMINE; SULFADIAZINE; VANCOMYCIN; VORICONAZOLE;

ADULT; CASE REPORT; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GRAFT RECIPIENT; HUMAN; LIVER TRANSPLANTATION; MALE; MEDICAL LITERATURE; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVIEW; SEROLOGY; TOXOPLASMOSIS;

LIVER TRANSPLANTATION; POLYMERASE CHAIN REACTION; TISSUE DONORS; TOXOPLASMOSIS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 34247589349     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2006.00187.x     Document Type: Review

References (35)

1. Jones JL. Toxoplasma gondii infection in the United States, 1999-2000. Emerg Infect Dis 2003 9: 1371 1374.
2. McCabe RE. Clinical spectrum in 107 cases of toxoplasmic lymphadenopathy. Rev Infect Dis 1987 9: 754 774.
3. Renoult E, Georges E, Biava MF, et al. Toxoplasmosis in kidney transplant recipients: report of six cases and review. Clin Infect Dis 1997 24: 625 634.
4. Mele A, Paterson PJ, Prentice HG, Leoni P, Kibbler CC. Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature. Bone Marrow Transplant 2002 29: 691 698.
5. Mayes JT, O'Connor BJ, Avery R, Castellani W, Carey W. Transmission of Toxoplasma gondii infection by liver transplantation. Clin Infect Dis 1995 21: 511 515.
6. Blanc-Jouvan M, Boibieux A, Fleury J, et al. Chorioretinitis following liver transplantation: detection of Toxoplasma gondii in aqueous humor. Clin Infect Dis 1996 22: 184 185.
7. Botterel F, Ichai P, Feray C, et al. Disseminated toxoplasmosis, resulting from infection of allograft, after orthotopic liver transplantation: usefulness of quantitative PCR. J Clin Microbiol 2002 40: 1648 1650.
8. Naot Y, Remington J. An enzyme-linked immunosorbent assay for detection of IgM antibodies to Toxoplasma gondii: use for diagnosis of acute acquired toxoplasmosis. J Infect Dis 1980 142: 757 766.
9. Sabin AB, Feldman HA. Dyes as microchemical indicators of a new immunity phenomenon affecting a protozoan parasite (Toxoplasma). Science 1948 108: 660 663.
10. Pelloux H, Brun E, Vernet G, et al. Determination of anti-Toxoplasma gondii immunoglobulin G avidity: adaption to the Vidas system (bioMérieux). Diagn Microbiol Infect Dis 1998 32: 69 73.
11. Danneman B, Vaughn W, Thulliez P, Remington JS. Differential agglutination test for diagnosis of recently acquired infection with Toxoplasma gondii. J Clin Microbiol 1990 28: 1928 1933.
12. Anthony CW. Disseminated toxoplasmosis in a liver transplant patient. J Am Med Womens Assoc 1972 27: 601 603.
13. Kusne S, Dummer JS, Ho M, et al. Self-limited Toxoplasma parasitemia after liver transplantation. Transplantation 1987 44: 457 458.
14. Singer MA, Hagler WS, Grossniklaus HE. Toxoplasma gondii retinochoroiditis after liver transplantation. Retina 1993 13: 40 45.
15. Singh N, Gayowski T, Marino IR. Toxoplasma gondii pneumonitis in a liver transplant recipient: implications for diagnosis. Liver Transpl Surg 1996 2: 299 300.
16. Lappalainen M, Jokiranta TS, Halme L, et al. Disseminated toxoplasmosis after liver transplantation: case report and review. Clin Infect Dis 1998 27: 1327 1328.
17. Hommann M, Schotte U, Voigt R, et al. Cerebral toxoplasmosis after combined liver-pancreas-kidney and liver-pancreas transplantation. Transplant Proc 2002 34: 2294 2295.
18. Wendum D, Carbonell N, Svrcek M, Chazouilleres O, Flejou JF. Fatal disseminated toxoplasmosis in a toxoplasma seropositive liver transplant recipient. J Clin Pathol 2002 55: 637.
19. Barcan LA, Dallurzo ML, Clara LO, et al. Toxoplasma gondii pneumonia in liver transplantation: survival after a severe case of reactivation. Transpl Infect Dis 2002 4: 93 96.
20. Podzamczer D, Salazar A, Jimenez J, et al. Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV. Ann Intern Med 1995 122: 755 761.
21. Wreghitt TG, McNeil K, Roth C, Wallwork J, McKee T, Parameshwar J. Antibiotic prophylaxis for the prevention of donor-acquired Toxoplasma gondii infection in transplant patients. J Infect 1995 31: 253 254.
22. Montoya JG, Giraldo LF, Efron B, et al. Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center. Clin Infect Dis 2001 33: 629 640. Epub 2001 Aug 6.
23. Luft BJ, Remington JS. AIDS commentary. Toxoplasmic encephalitis. J Infect Dis 1988 157: 1 6.
24. Katlama C, De Wit S, O'Doherty E, Van Glabeke M, Clumeck N. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS. Clin Infect Dis 1996 22: 268 275.
25. Dannemann B, McCutchan JA, Israelski D, et al. Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group. Ann Intern Med 1992 116: 33 43.
26. Chirgwin K, Hafner R, Leport C, et al. Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche sur le SIDA, Essai 039. Clin Infect Dis 2002 34: 1243 1250.
27. Jacobson JM, Hafner R, Remington J, et al. ACTG 156 Study Team. Dose-escalation, phase I/II study of azithromycin and pyrimethamine for the treatment of toxoplasmic encephalitis in AIDS. AIDS 2001 15: 583 589.
28. Katlama C, Mouthon B, Gourdon D, Lapierre D, Rousseau F. Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group. AIDS 1996 10: 1107 1112.
29. de Gans J, Portegies P, Reiss P, et al. Pyrimethamine alone as maintenance therapy for central nervous system toxoplasmosis in 38 patients with AIDS. AIDS 1992 5: 137 142.
30. Patel R. Disseminated toxoplasmosis after liver transplantation. Clin Infect Dis 1999 29: 705 706.
31. Martino R, Bretagne S, Einsele H, et al. Infectious Disease Working Party of the European Group for Blood and Marrow Transplantation. Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation. Clin Infect Dis 2005 40: 67 78. Epub 2004 Dec 7.
32. Wulf MW, van Crevel R, Portier R, et al. Toxoplasmosis after renal transplantation: implications of a missed diagnosis. J Clin Microbiol 2005 43: 3544 3547.
33. Cinque P, Scarpellini P, Vago L, Linde A, Lazzarin A. Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction. AIDS 1997 11: 1 17.
34. Jones CD, Okhravi N, Adamson P, Tasker S, Lightman S. Comparison of PCR detection methods for B1, P30, and 18S rDNA genes of T. gondii in aqueous humor. Invest Ophthalmol Vis Sci 2000 41: 634 644.
35. Cockerill FR, Uhl FR. Applications and challenges of real-time PCR for the clinical microbiology laboratory. In: Reischl U, Wittwer C, Cockerill F, eds. Rapid Cycle Real-Time PCR Methods and Applications. New York: Springer, 2002 3 27.